Lycopene and Lycopene for Prostate cancer risk (observational)
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Lycopene
The tomato carotenoid with modest prostate and cardiovascular signals — better from food than pills.
Grade C2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
Lycopene for Prostate cancer risk (observational)
Evidence grade C — Food > supplement
Grade C1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Lycopene | Lycopene for Prostate cancer risk (observational) |
|---|---|---|
| Prostate cancer risk (observational) | Evidence grade CSmall effectmixedFood > supplement | Evidence grade CSmall effectmixedFood > supplement |
Graded only in Lycopene
- Cardiovascular markers Small effectEvidence grade C
Graded only in Lycopene for Prostate cancer risk (observational)
None — every outcome it grades is graded in both.
What each entry says about the other
- Lycopene for Prostate cancer risk (observational)’s entry · Goes with: Read the full Lycopene monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.